Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

616 Articles

Chris Lange | Jan 9, 2015 at 11:00 AM EST

Gilead Continues to Recover from Express Scripts Loss

Gilead Sciences was picked up by Anthem to provide its hepatitis C drug as the primary option for patients.

Chris Lange | Dec 29, 2014 at 10:45 AM EST

Is Gilead Already Coming Back Into Favor?

Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the…

Chris Lange | Dec 23, 2014 at 12:15 PM EST

Analysts Predict Big Value Trap for Gilead Investors

Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.

Chris Lange | Dec 22, 2014 at 1:20 PM EST

What the AbbVie and Express Script Deal Means for Gilead

AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.

Jon C. Ogg | Dec 11, 2014 at 8:20 AM EST

Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More

Thursday's top analyst upgrades and downgrades from 24/7 Wall St. include ARIAD Pharmaceuticals, FedEx, Genpact, Suncor Energy, Travelers and UPS.

Jon C. Ogg | Nov 14, 2014 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Harley-Davidson, Lululemon, Nike, SunPower, Walmart and More

Friday's top analyst upgrades, downgrades and initiations include Harley-Davidson, Lululemon, Nike, SunPower and Walmart.

Lee Jackson | Nov 13, 2014 at 9:15 AM EST

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

A new research report from the analysts at UBS focuses on four companies that stand to benefit from rising demand…

Paul Ausick | Oct 27, 2014 at 10:45 AM EDT

The 7 Most Heavily Shorted NYSE Stocks

Only one of the seven stocks traded on the New York Stock Exchange with the largest number of shares held…

Lee Jackson | Oct 17, 2014 at 8:35 AM EDT

UBS’s Big List of Quality Stocks to Buy Now

UBS polled all of its analysts, who came up with 26 stocks by now. Here are the ones that offer…

Trey Thoelcke | Oct 10, 2014 at 7:20 AM EDT

Sprint Drops From the 5 Most Shorted NYSE Stocks

The most shorted stocks on the New York Stock Exchange at the September 30 settlement dates saw rising short interest…

Trey Thoelcke | Sep 25, 2014 at 7:55 AM EDT

AbbVie Joins the 5 Most Shorted NYSE Stocks

Short sellers shied away from Bank of American enough that it slipped out of the top five most shorted stocks…

Jon C. Ogg | Sep 23, 2014 at 1:30 PM EDT

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have…

Lee Jackson | Sep 15, 2014 at 10:55 AM EDT

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

A new research report from UBS focuses on four top companies that are making great strides in treatments for patients…

Trey Thoelcke | Sep 11, 2014 at 7:35 AM EDT

Sprint Joins the 5 Most Shorted NYSE Stocks

Surges in short interest between the August 15 and August 29 settlement dates pushed Sprint into the top five most…

Jon C. Ogg | Sep 3, 2014 at 2:10 PM EDT

Is Infinity Fully Valued Now, or Is More Upside Left?

Infinity Pharmaceuticals will partner with Abbvie to further develop and commercialize IPI-145, also known as Duvelisib.

1 … 37 38 39 40 41 42

AbbVie : ABBV

All AbbVie Articles

Gilead Continues to Recover from Express Scripts Loss

Is Gilead Already Coming Back Into Favor?

Analysts Predict Big Value Trap for Gilead Investors

What the AbbVie and Express Script Deal Means for Gilead

Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More

Top Analyst Upgrades and Downgrades: Harley-Davidson, Lululemon, Nike, SunPower, Walmart and More

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

The 7 Most Heavily Shorted NYSE Stocks

UBS’s Big List of Quality Stocks to Buy Now

Sprint Drops From the 5 Most Shorted NYSE Stocks

AbbVie Joins the 5 Most Shorted NYSE Stocks

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

Sprint Joins the 5 Most Shorted NYSE Stocks

Is Infinity Fully Valued Now, or Is More Upside Left?

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

AbbVie : ABBV

All AbbVie Articles

Gilead Continues to Recover from Express Scripts Loss

Is Gilead Already Coming Back Into Favor?

Analysts Predict Big Value Trap for Gilead Investors

What the AbbVie and Express Script Deal Means for Gilead

Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More

Top Analyst Upgrades and Downgrades: Harley-Davidson, Lululemon, Nike, SunPower, Walmart and More

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

The 7 Most Heavily Shorted NYSE Stocks

UBS’s Big List of Quality Stocks to Buy Now

Sprint Drops From the 5 Most Shorted NYSE Stocks

AbbVie Joins the 5 Most Shorted NYSE Stocks

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

Sprint Joins the 5 Most Shorted NYSE Stocks

Is Infinity Fully Valued Now, or Is More Upside Left?

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account